Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02019004 · ClinicalTrials.gov registry record · Early Phase 1
A Pilot Study Testing Onabotulinum Toxin A Versus Incobotulinum Toxin A Injections for Facial Wrinkles
A Early Phase 1 study of Wrinkles, sponsored by Northwestern University.
- Active
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT02019004 is a Early Phase 1 study of Wrinkles that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 20 participants, below the 53-participant average among 7 other Wrinkles trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02019004, a Early Phase 1 study of Wrinkles, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effectiveness of Botox® (Onabotulinum Toxin A) versus Xeomin® (incobotulinum toxin A) for the treatment of forehead and glabellar (vertical lines between the eyebrows) wrinkles.
Conditions Studied
Interventions
- DRUG Incobotulinum Toxin A
- DRUG Onabotulinum Toxin A
Study Locations (1)
Illinois
- Northwestern University Department of Dermatology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-11 |
| Est. Completion | 2025-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02019004
The ClinicalTrials.gov registry entry for NCT02019004 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 53-participant average among 7 other Wrinkles trials with a reported enrollment target (62% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Wrinkles appearing as the primary indexed condition, and to 2 interventions - of which Incobotulinum Toxin A is the first listed.
NCT02019004 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT02019004 about?
NCT02019004 is a clinical study titled "A Pilot Study Testing Onabotulinum Toxin A Versus Incobotulinum Toxin A Injections for Facial Wrinkles". The purpose of this study is to compare the effectiveness of Botox® (Onabotulinum Toxin A) versus Xeomin® (incobotulinum toxin A) for the treatment of forehead and glabellar (vertical lines between the eyebrows) wrinkles.
What is the current status of trial NCT02019004?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2013-11. Estimated completion is 2025-12.
What conditions does trial NCT02019004 study?
This clinical trial studies the following conditions: Wrinkles.
What interventions are being tested in trial NCT02019004?
The interventions under investigation include: Incobotulinum Toxin A (DRUG), Onabotulinum Toxin A (DRUG).
Who is sponsoring clinical trial NCT02019004?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02019004 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wrinkles
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fractional Laser vs. Ultrasound for Periorbital Wrinkles
ACTIVE NOT RECRUITING · Early Phase 1
-
Evaluating the Safety and Efficacy of the Pico Laser With a Specialized Lens Array for the Treatment of Wrinkles
COMPLETED · NA
-
The Effect of Topical Almond Oil vs. Topical Retinol on The Appearance of Facial Wrinkles
COMPLETED · NA
-
A Clinical Study to Evaluate Efficacy and Safety of a Cosmetic Product in the Treatment of Facial Lines
COMPLETED · NA
-
Pilot Study of Triphala and Rubia Cordifolia on Gut Microbiome and Skin
COMPLETED · NA
-
Study of BOTOX and JUVEDERM for Treatment of Moderate to Severe Facial Wrinkles and Folds
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.